Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients: A Retrospective Observational Study

OBJECTIVES: There was initially insufficient understanding regarding suitable pharmacological treatment for pediatric Coronavirus Disease 2019 (COVID-19) patients. Lopinavir-ritonavir (LPV/r) was originally used for the treatment of Human Immunodeficiency Virus-1 (HIV-1) infection. It was also used...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Carlos K. H., Low, Marshall C. H., Kwok, Ashley C. Y., Lui, Angel Y. C., Lau, Kristy T. K., Au, Ivan C. H., Xiong, Xi, Chung, Matthew S. H., Kwan, Mike Y. W., Lau, Eric H. Y., Cowling, Benjamin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012665/
https://www.ncbi.nlm.nih.gov/pubmed/35428969
http://dx.doi.org/10.1007/s40272-022-00500-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012665/
https://www.ncbi.nlm.nih.gov/pubmed/35428969
http://dx.doi.org/10.1007/s40272-022-00500-7

Ejemplares similares